Tectonic Therapeutic, Inc.
$ 23.93
3.55%
26 Feb - close price
- Market Cap 432,533,000 USD
- Current Price $ 23.93
- High / Low $ 24.65 / 22.00
- Stock P/E N/A
- Book Value 14.30
- EPS -2.69
- Next Earning Report 2026-03-19
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.22 %
- ROE -0.32 %
- 52 Week High 27.33
- 52 Week Low 13.70
About
Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is headquartered in Watertown, Massachusetts.
Analyst Target Price
$78.25
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-14 | 2025-05-07 | 2025-03-12 | 2024-11-07 | 2024-08-14 | 2024-05-09 | 2024-03-20 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-23 |
| Reported EPS | -1.02 | -1.07 | -0.93 | -0.8364 | -1.2 | -4.34 | -1.8 | -0.5 | -0.48 | 1.52 | -0.57 | -0.57 |
| Estimated EPS | -0.13 | -1.32 | -1.0925 | -1.3867 | -0.84 | -1.3 | -0.36 | -0.43 | -0.355 | -0.5409 | -0.55 | -0.4929 |
| Surprise | -0.89 | 0.25 | 0.1625 | 0.5503 | -0.36 | -3.04 | -1.44 | -0.07 | -0.125 | 2.0609 | -0.02 | -0.0771 |
| Surprise Percentage | -684.6154% | 18.9394% | 14.8741% | 39.6841% | -42.8571% | -233.8462% | -400% | -16.2791% | -35.2113% | 381.0131% | -3.6364% | -15.6421% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-19 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -1.11 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TECX
2026-02-18 10:42:00
This article provides an AI-driven analysis of Avrobio Inc. (NASDAQ: TECX), highlighting near-term weak sentiment within a broader long-term weak bias, but with mid-term strength. It details specific trading strategies for different risk profiles, including long, breakout, and short positions, along with multi-timeframe signal analysis and support/resistance levels. The analysis emphasizes an exceptional risk-reward short setup.
2026-01-27 08:26:00
This article analyzes Avrobio Inc. (NASDAQ: TECX) using quantitative signal sets, noting a near-term strong sentiment challenging persistent mid and long-term weakness. It highlights an exceptional 124.8:1 risk-reward setup targeting a 36.0% gain. The piece also details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis.
2026-01-16 06:58:35
This article provides an AI-driven liquidity mapping analysis for Avrobio Inc. (NASDAQ: TECX), indicating weak sentiment across all time horizons that supports a short bias. It details exceptional risk-reward setups and outlines specific institutional trading strategies including long, momentum breakout, and short positions with defined entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal strengths and support/resistance levels.
2026-01-05 06:10:00
The article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting a near-term weak sentiment within a broader long-term weak bias, despite underlying mid-term strength. It emphasizes a significant 112.3:1 risk-reward short setup, targeting a 33.9% downside with only 0.3% risk. The analysis provides specific entry, target, and stop-loss zones for various trading strategies—position, momentum breakout, and risk hedging—based on AI-generated multi-timeframe signals.
2025-12-25 04:46:00
This article provides an AI-driven analysis of Avrobio Inc. (NASDAQ: TECX), highlighting divergent sentiment across different time horizons and testing resistance levels. It outlines specific institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with detailed entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
2025-12-14 02:52:00
This article provides a detailed analysis of Avrobio Inc. (TECX), highlighting near-term weak sentiment and a mid-channel oscillation pattern. It presents three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis and risk-reward ratios. The analysis indicates an exceptional 141.7:1 risk-reward short setup.
